Investment

Creavo Medical Technologies is a UK-based, privately held medical technology company developing innovative diagnostic technologies for acute medical settings. It was established to bring to market a technology developed by Professor Ben Varcoe, Chair of Quantum Information Science at the University of Leeds.

As an industry, healthcare is a key global growth market and one of the largest in the world at close to 10% of global GDP according to research by Deloitte. The European medical technology market is estimated at roughly €100bn, 31% of the world market. It makes up 7.5% of total healthcare spend and, according to MedTech Europe, is set to grow in the period 2017-2019, making it an attractive investment opportunity.

Creavo has already held three successful rounds of investment, raising more than £20 million and currently works closely with its investment partners including IP Group plc, the developer of intellectual property-based businesses, which has backed the company from inception. The company has also attracted other investors, including Parkwalk Advisors Ltd and Puhua Capital Ltd, plus long-term support from the University of Leeds.

In February 2016, Creavo successfully raised £4.6 million to drive its first product, Vitalscan to clinical studies. In June 2017, it raised a further £13.4 million in an oversubscribed funding round to grow the business and move the device towards a full commercial launch in Europe, as well as further research to expand its use into other applications. The device, which is launching as part of a largescale multi-centre clinical trial, has been developed to meet an urgent medical need worth in excess of $5bn worldwide: to help physicians accurately and quickly rule out significant ischaemic heart disease, including heart attacks, through a simple, non-invasive three to five-minute scan at a patient’s bedside.


Key Company Milestones

Creavo Medical Technologies secures U.S. FDA 510(k)


Technology has the potential to revolutionise emergency department triage of chest pain patients. Developer of innovative medical diagnostic technology, Creavo Medical Technologies, has rece...

Read more...

Creavo Medical Technologies closes £13.4m ($17m) funding round


Creavo Medical Technologies, the UK-based med-tech company, has announced that it has raised a further £13.4m ($17m) in equity funding. The round was oversubscribed and exceeded Creavo’s ...

Read more...

Heart device on trial that could save the NHS £200 million a year


A new cardiac scanning device that could save the NHS £200 million a year is being trialled at four of the UK’s largest emergency departments (Bristol, Nottingham, Leicester and Sheffield...

Read more...

Creavo appoints new CFO


Creavo Medical Technologies, a UK-based, privately held medical devices company, has announced the appointment of John von Benecke as Chief Financial Officer (CFO) to help the company with i...

Read more...

Creavo’s VitalScan receives CE mark


Creavo Medical Technologies, an emerging British company developing diagnostics technology for acute medical settings, is today Wednesday 23 November pleased to announce that its first devic...

Read more...

Name change aligns company to greater global ambition


Quantum Imaging is pleased to announce that it is changing its name to Creavo Medical Technologies Ltd (Creavo) in a move to better align its brand identity with its ambition as an innovativ...

Read more...


If you would like to know more about investment opportunities, please contact Steve Parker at steve.parker@creavomedtech.com.